Current data on the cardiovascular effects of COVID-19.
作者信息
Vlachakis Panayotis K, Tentolouris Anastasios, Tousoulis Dimitris, Tentolouris Nikolaos
机构信息
First Department of Propaedeutic Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece.
1st Cardiology Department, National and Kapodistrian University of Athens University, Medical School, Hippokration Hospital, Athens, Greece.
出版信息
Hellenic J Cardiol. 2020 Jan-Feb;61(1):46-48. doi: 10.1016/j.hjc.2020.04.001. Epub 2020 Apr 18.
Abstract
摘要
相似文献
1
Current data on the cardiovascular effects of COVID-19.
Hellenic J Cardiol. 2020 Jan-Feb;61(1):46-48. doi: 10.1016/j.hjc.2020.04.001. Epub 2020 Apr 18.
2
Is COVID-19 more severe in older men?
Postgrad Med J. 2020 Jul;96(1137):426. doi: 10.1136/postgradmedj-2020-137867. Epub 2020 May 13.
3
Diabetes mellitus: Lessons from the COVID-19 pandemic.
Hellenic J Cardiol. 2020 Jan-Feb;61(1):1-2. doi: 10.1016/j.hjc.2020.03.009. Epub 2020 May 18.
4
COVID-19 and myocardial injury: is there a role for interleukin-1 inhibition?
J Cardiovasc Med (Hagerstown). 2020 Jul;21(7):465-466. doi: 10.2459/JCM.0000000000000998.
5
Myocyte-Specific Upregulation of in Cardiovascular Disease: Implications for SARS-CoV-2-Mediated Myocarditis.
Circulation. 2020 Aug 18;142(7):708-710. doi: 10.1161/CIRCULATIONAHA.120.047911. Epub 2020 Jun 22.
6
Coronavirus disease 2019 and the cardiovascular system: Impacts and implications.
Indian Heart J. 2020 Jan-Feb;72(1):1-6. doi: 10.1016/j.ihj.2020.03.006. Epub 2020 Apr 9.
7
Kidney diseases in the time of COVID-19: major challenges to patient care.
J Clin Invest. 2020 Jun 1;130(6):2749-2751. doi: 10.1172/JCI138871.
8
COVID-19 and the Heart.
Circ Res. 2020 May 8;126(10):1443-1455. doi: 10.1161/CIRCRESAHA.120.317055. Epub 2020 Apr 7.
9
Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome.
Circulation. 2020 Jun 9;141(23):1903-1914. doi: 10.1161/CIRCULATIONAHA.120.047349. Epub 2020 Apr 16.
10
Focus on the Crosstalk between COVID-19 and Urogenital Systems.
J Urol. 2020 Jul;204(1):7-8. doi: 10.1097/JU.0000000000001068. Epub 2020 Apr 3.
引用本文的文献
1
Cardiac markers of multisystem inflammatory syndrome in children (MIS-C) in COVID-19 patients: A meta-analysis.
Am J Emerg Med. 2021 Nov;49:62-70. doi: 10.1016/j.ajem.2021.05.044. Epub 2021 May 18.
2
Getting to the Heart of the Matter: Myocardial Injury, Coagulopathy, and Other Potential Cardiovascular Implications of COVID-19.
Int J Vasc Med. 2021 Apr 22;2021:6693895. doi: 10.1155/2021/6693895. eCollection 2021.
3
ECG markers of malignant arrhythmias and in-hospital outcome of COVID-19 pneumonia.
J Arrhythm. 2021 Jan 24;37(2):426-431. doi: 10.1002/joa3.12506. eCollection 2021 Apr.
4
Electrocardiographic markers of increased risk of sudden cardiac death in patients with COVID-19 pneumonia.
Ann Noninvasive Electrocardiol. 2021 May;26(3):e12824. doi: 10.1111/anec.12824. Epub 2021 Jan 19.
5
COVID-19-related myocarditis and cholinergic anti-inflammatory pathways.
Hellenic J Cardiol. 2021 Jul-Aug;62(4):265-269. doi: 10.1016/j.hjc.2020.12.004. Epub 2020 Dec 8.
6
Concerns for management of STEMI patients in the COVID-19 era: a paradox phenomenon.
J Thromb Thrombolysis. 2020 Nov;50(4):809-813. doi: 10.1007/s11239-020-02236-y.
7
Bradycardia in Patients With COVID-19: A Calm Before the Storm?
Cureus. 2020 Jun 13;12(6):e8599. doi: 10.7759/cureus.8599.
本文引用的文献
1
Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers.
Hypertension. 2020 Jun;75(6):1382-1385. doi: 10.1161/HYPERTENSIONAHA.120.15082. Epub 2020 Mar 25.
2
Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin.
Eur Heart J. 2021 Jan 7;42(2):206. doi: 10.1093/eurheartj/ehaa190.
3
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
4
Coronavirus disease 2019: What we know?
J Med Virol. 2020 Jul;92(7):719-725. doi: 10.1002/jmv.25766. Epub 2020 Mar 28.
5
Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis.
Prog Cardiovasc Dis. 2020 May-Jun;63(3):390-391. doi: 10.1016/j.pcad.2020.03.001. Epub 2020 Mar 10.
6
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.
JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994.
7
Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China.
Clin Res Cardiol. 2020 May;109(5):531-538. doi: 10.1007/s00392-020-01626-9. Epub 2020 Mar 11.
8
Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China.
J Infect Dev Ctries. 2020 Feb 29;14(2):125-128. doi: 10.3855/jidc.12600.
9
SARS-CoV-2: a potential novel etiology of fulminant myocarditis.
Herz. 2020 May;45(3):230-232. doi: 10.1007/s00059-020-04909-z.
10
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.
Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3.
Zotero 插件